Table of Contents Author Guidelines Submit a Manuscript
Journal of Skin Cancer
Volume 2018, Article ID 9602540, 13 pages
https://doi.org/10.1155/2018/9602540
Research Article

Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management

1Chris O’Brien Lifehouse, Camperdown, NSW, Australia
2Concord Repatriation General Hospital, Sydney, NSW, Australia
3Centenary Institute, Sydney, NSW, Australia
4Sydney Medical School, University of Sydney, Camperdown, NSW, Australia
5Royal Prince Alfred Hospital, Camperdown, NSW, Australia

Correspondence should be addressed to Anna J. Lomax; ua.gro.hl@xamol.anna

Received 15 August 2017; Revised 31 October 2017; Accepted 6 November 2017; Published 21 January 2018

Academic Editor: Arash Kimyai-Asadi

Copyright © 2018 Anna J. Lomax et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Anna J. Lomax, Jennifer Lim, Robert Cheng, et al., “Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management,” Journal of Skin Cancer, vol. 2018, Article ID 9602540, 13 pages, 2018. https://doi.org/10.1155/2018/9602540.